# Comparison of Two Neuromuscular Transmission Monitors Based on Acceleromyography: TOF-Watch SX® and TOFScan®

> **NCT02880787** · NA · UNKNOWN · sponsor: **Central Hospital, Nancy, France** · enrollment: 142 (estimated)

## Conditions studied

- Curarisation
- Neuromuscular Monitoring

## Interventions

- **DRUG:** Rocuronium
- **DEVICE:** Neuromuscular monitoring with TOFScan® and TOF-Watch SX®

## Key facts

- **NCT ID:** NCT02880787
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 142 (ESTIMATED)
- **Last updated:** 2016-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02880787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02880787, "Comparison of Two Neuromuscular Transmission Monitors Based on Acceleromyography: TOF-Watch SX® and TOFScan®". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02880787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*